NxStage Medical Competitors and Similar CompaniesClear all

NxStage Medical's competitors and similar companies include Biosense Webster, MED-EL, Terumo Medical and Smith & Nephew.

	NxStage Medical NxStage Medical is a medical device company that develops, manufactures and markets innovative dialysis systems for the treatment of kidney failure.	Biosense Webster Biosense Webster is a company focused on the diagnosis and treatment of cardiac arrhythmias.	MED-EL MED-EL is a company providing hearing loss solutions.	Terumo Medical Terumo Medical is a company that develops medical devices.	Smith & Nephew Smith & Nephew is a medical technology company.
Founding Date	Founding Date 1998	Founding Date 1970	Founding Date 1989	Founding Date 1972	Founding Date 1856
Type	Type Subsidiary	Type Subsidiary	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare medical devices medtech	Tags Healthcare healthtech medical devices medtech
Locations	Locations Lawrence, US HQ Atlanta, US Baton Rouge, US Birmingham, US Brunswick, US Buffalo, US Casselberry, US see more	Locations Irvine, US HQ	Locations Innsbruck, AT HQ	Locations Somerset, US HQ Sao Paulo, BR Vaughan, CA Hangzhou, CN Ciudad De México, MX Breinigsville, US Elkton, US see more	Locations Watford, GB HQ Buenos Aires, AR Macquarie Park, AU Schwechat, AT Zaventem, BE São Paolo, BR Mississauga, CA see more
Employees	Employees 6611% decrease	Employees 2,9923% decrease	Employees 1,9611% increase	Employees 2,7491% increase	Employees 17,349
Financial
Revenue (est.)	Revenue (est.) $393.9m (FY, 2017)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $6.2b (FY, 2025)
Cost of goods	Cost of goods $225.7m (FY, 2017)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.4b (FY, 2025)
Gross profit	Gross profit $168.3m (FY, 2017)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $4.8b (FY, 2025)
Net income	Net income ($14m) (FY, 2017)	Net income N/A	Net income N/A	Net income N/A	Net income $625m (FY, 2025)